Boosting immune cell memory to improve vaccines and cancer immunotherapy
(University of California - San Diego) In mouse experiments, researchers at University of California San Diego School of Medicine have discovered that drugs that activate the cells' proteasome, or recycling center, tip the balance in favor of memory CD8+ T cells. This approach could be used to improve how well vaccines and immunotherapies work and how long they last. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 28, 2017 Category: Cancer & Oncology Source Type: news

HPV Vaccine Uptake Lags in Cancer Survivors (CME/CE)
(MedPage Today) -- Lack of provider recommendation a key factor (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - August 25, 2017 Category: American Health Source Type: news

HPV vaccine: What is the virus linked to anal cancer and how is it spread?
HPV has been linked to anal cancer, cervical cancer and mouth cancer, but few people know what the virus is or how people can be infected by it. (Source: Daily Express - Health)
Source: Daily Express - Health - August 25, 2017 Category: Consumer Health News Source Type: news

More U.S. teens getting vaccinated against HPV
Six out of 10 U.S. parents are choosing to get their children vaccinated against cancer-causing HPV. (Source: Health News - UPI.com)
Source: Health News - UPI.com - August 25, 2017 Category: Consumer Health News Source Type: news

More U.S. Teens Getting Vaccinated Against HPV
But rates still lagging against the cancer - causing virus that's caused by sexual contact, CDC says (Source: Fertility News - Doctors Lounge)
Source: Fertility News - Doctors Lounge - August 25, 2017 Category: Reproduction Medicine Tags: Infections, Oncology, Pediatrics, Reproductive Medicine, News, Source Type: news

Fewer Than Half Of Teens Up To Date On HPV Vaccine
Rrates still lagging against the cancer-causing virus that's caused by sexual contact, CDC says (Source: WebMD Health)
Source: WebMD Health - August 25, 2017 Category: Consumer Health News Source Type: news

Vaccine makers rely on "statistical gimmicks" to obscure the truth about HPV vaccines harming children
(Natural News) It has been more than a decade since Gardasil, the first ever vaccine specifically intended to prevent cancer, was approved for use by the FDA. At the time, Gardasil was touted as a miracle shot that would prevent young girls from being infected with the human papillomavirus (HPV), which causes genital warts, as... (Source: NaturalNews.com)
Source: NaturalNews.com - August 25, 2017 Category: Consumer Health News Source Type: news

HPV Vaccine Rates Low in Childhood Cancer Survivors HPV Vaccine Rates Low in Childhood Cancer Survivors
The uptake of the HPV vaccine is low in the United States and even lower among childhood cancer survivors.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 24, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

More U.S. Teens Getting Vaccinated Against HPV
But rates still lagging against the cancer-causing virus that's caused by sexual contact, CDC saysSource: HealthDay Related MedlinePlus Pages: Childhood Immunization, HPV, Teen Health (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - August 24, 2017 Category: Consumer Health News Source Type: news

More U.S. Teens Still Need To Get Vaccinated Against HPV
THURSDAY, Aug. 24, 2017 -- Six out of 10 U.S. parents are choosing to get their children vaccinated against the cancer-causing human papillomavirus (HPV), which is spread by sexual contact, federal health officials reported Thursday. The bad news:... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 24, 2017 Category: General Medicine Source Type: news

More U.S. Teens Getting Vaccinated Against HPV
THURSDAY, Aug. 24, 2017 -- Six out of 10 U.S. parents are choosing to get their children vaccinated against the cancer-causing human papillomavirus (HPV), which is spread by sexual contact, federal health officials reported Thursday. The bad news:... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 24, 2017 Category: General Medicine Source Type: news

HPV vaccination rates lag for vulnerable population of childhood cancer survivors
(St. Jude Children's Research Hospital) Research suggests health providers are key to boosting HPV vaccination rates of childhood cancer survivors, who, as a group, are at increased risk for second cancers associated with the human papillomavirus. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 24, 2017 Category: Cancer & Oncology Source Type: news

New treatment cures, vaccinates mice against cancer
Researchers at Duke University have successfully cured and vaccinated mice against cancer in a recent small study using nanotechnology and immunotherapy. (Source: Health News - UPI.com)
Source: Health News - UPI.com - August 18, 2017 Category: Consumer Health News Source Type: news

Nanotech, immunotherapy combo vaccinates mouse against cancer
Researchers from Duke University combined an FDA-approved cancer immunotherapy with gold nanostars to boost the cancer-killing abilities of both therapies, according to a study published this week in Scientific Reports. The combination therapy cured two mice and vaccinated one against bladder cancer, the team reported. Get the full story at our sister site, Drug Delivery Business News. The post Nanotech, immunotherapy combo vaccinates mouse against cancer appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - August 18, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Oncology Pharmaceuticals Research & Development Duke University Source Type: news

July 2016
Safeguarding Our Health : Vaccines Protect Us All A Blurry Worldview : Understanding Myopia Physical Activity Linked to Reduced Cancer Risk Understanding Aphasia Test Your Sense of Pitch (Source: NIH News in Health)
Source: NIH News in Health - August 16, 2017 Category: Consumer Health News Source Type: news

November 2015
A Look at Epilepsy : Electrical Outbursts in the Brain Keep Your Skin Healthy : Protecting Your Outer Self Sidestep the Flu: Get Vaccinated Tumor Test Helps Tailor Breast Cancer Treatments NIH Research Matters (Source: NIH News in Health)
Source: NIH News in Health - August 16, 2017 Category: Consumer Health News Source Type: news

March 2015
Be a Partner in Clinical Research : Help Others, Help Yourself Better Check Your Bowels : Screening for Colon and Rectal Cancer Are You at Risk for Alcohol-Medication Interactions? Measles: Preventable with Vaccines National Center for Complementary and Integrative Health (Source: NIH News in Health)
Source: NIH News in Health - August 16, 2017 Category: Consumer Health News Source Type: news

Former MLA who survived cancer calls for national HPV vaccination program
A study published by the Canadian Medical Association Journal showed a significant rise in the proportion of oral cancers caused by the HPV in Canada. (Source: CBC | Health)
Source: CBC | Health - August 15, 2017 Category: Consumer Health News Tags: News/Canada/Nova Scotia Source Type: news

Cytology versus HPV testing for cervical cancer screening in the general population: a DTA Review from the Cochrane Gynaecological, Neuro-oncology and Orphan Cancers Group, (CGNOC)
Cochrane Reviews are systematic reviews of research in health care and policy. They are internationally recognized as a high-quality source of evidence for decision-making. They collate and summarize all the best available research evidence on the effects of healthcare interventions or the accuracy of diagnostic tests into a systematic review.Diagnostic Test Accuracy Reviews (DTA) provide essential information regarding the accuracy of the available diagnostic tools for key decision makers, including patients, clinicians, guideline developers and researchers.  The purpose of a Cochrane DTA review is very like the purp...
Source: Cochrane News and Events - August 14, 2017 Category: Information Technology Authors: mumoquit at cochrane.org Source Type: news

Fred Hutch takes step toward 'moonshot' goal with new pathogen-caused cancer center
Fred Hutch faculty members with expertise in infectious diseases, vaccines, immunotherapy, public health sciences, and cancer biology will all collaborate to fine new ways to prevent and cure cancers caused by viruses and bacteria. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - August 10, 2017 Category: Health Management Authors: Coral Garnick Source Type: news

Fred Hutch takes step toward 'moonshot' goal with new pathogen-caused-cancer center
Fred Hutch faculty members with expertise in infectious diseases, vaccines, immunotherapy, public health sciences, and cancer biology will collaborate on new ways to prevent and cure cancers caused by viruses and bacteria. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 10, 2017 Category: Biotechnology Authors: Coral Garnick Source Type: news

Fred Hutch takes step toward 'moonshot' goal with new pathogen-caused-cancer center
Fred Hutch faculty members with expertise in infectious diseases, vaccines, immunotherapy, public health sciences, and cancer biology will collaborate on new ways to prevent and cure cancers caused by viruses and bacteria. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 10, 2017 Category: American Health Authors: Coral Garnick Source Type: news

TapImmune broadens TPIV200 ’s Phase II trial for ovarian cancer
US-based immuno-oncology firm TapImmune has amended the Phase II clinical trial of its therapeutic peptide vaccine TPIV200 following discussions with the US Food and Drug Administration (FDA). (Source: Drug Development Technology)
Source: Drug Development Technology - August 10, 2017 Category: Pharmaceuticals Source Type: news

Personalized Vaccines May One Day Prevent Skin Cancer Relapses
"If every patient has a different set of tumors, we can make a vaccine tailored to each patient." (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - August 7, 2017 Category: Consumer Health News Source Type: news

Prevention of HPV-Related Oral Cancer by Dentists: Assessing the Opinion of Dutch Dental Students
Journal of Cancer Education pp 1 –8AbstractThe aim of this study is to assess dental students ’ opinions of the dentists’ role in primary prevention of human papillomavirus (HPV)-related oral cancer using a cross-sectional web-based survey. A questionnaire, containing questions about knowledge of HPV and oral cancer, confidence in head and neck examination and role of the dentist in preventing HPV-related oral cancer, was sent to all students of the Academic Centre of Dentistry Amsterdam (n = 912). One hundred and twenty-six (n = 126) students completed the questionnaire. Significantly...
Source: Dental Technology Blog - August 2, 2017 Category: Dentistry Source Type: news

Generex combines AE37 with Merck ’s Keytruda in Phase II trial for TNBC
Generex Biotechnology has signed a clinical trial collaboration agreement through its Antigen Express division to combine its cancer vaccine AE37 with Merck ’s Keytruda (pembrolizumab) in a Phase II clinical trial for patients with triple-negative bre… (Source: Drug Development Technology)
Source: Drug Development Technology - August 2, 2017 Category: Pharmaceuticals Source Type: news

Statistical analysis for optimal immunization: New insights into T cell development
(Technical University of Munich (TUM)) When T cells encounter an antigen, they proliferate and produce various types of daughter cells. A team at the Technical University of Munich (TUM) has now refuted the prevailing hypothesis that this immune response is largely predetermined by the individual structure of the T cell receptor. Instead, the influence of the T cell receptor can be described only in probabilistic terms. Such mathematical models may help to improve the design of future vaccination strategies. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 31, 2017 Category: Cancer & Oncology Source Type: news

Hopkins Nursing—Dean on Chronic Disease / Pediatrics
Hopkins Nursing—Dean on Chronic Disease / Pediatrics body,#bodyTable,#bodyCell{ height:100% !important; margin:0; padding:0; width:100% !important; } table{ border-collapse:collapse; } img,a img{ border:0; outline:none; text-decoration:none; } h1,h2,h3,h4,h5,h6{ margin:0; padding:0; } p{ margin:1em 0; padding:0; } a{ word-wrap:break-word; } .mcnPreviewText{ display:none !important; } .ReadMsgBody{ width:100%; } .ExternalClass{ width:100%; } .ExternalClass,.ExternalClass p,.ExternalClass span,.ExternalClass font,.ExternalClass t...
Source: Johns Hopkins University and Health Systems Archive - July 27, 2017 Category: Nursing Source Type: news

Infections in immigrants now pushing governments to mandate MORE vaccine injections for citizens who don't even carry the diseases
(Natural News) In the United Kingdom, ALL babies will be FORCED to receive the Infanrix Hexa vaccine to protect them against a deadly cancer-causing virus. Experts fear hepatitis B is becoming a common issue due to immigration. Therefore, starting from August 1 this year every baby born in the U.K. will receive three Hexa jabs... (Source: NaturalNews.com)
Source: NaturalNews.com - July 27, 2017 Category: Consumer Health News Source Type: news

Flu viral strain found to actually CURE liver cancer in groundbreaking research that obliterates medical narratives of the status quo
(Natural News) You don’t have be in favor of vaccines to appreciate the value of viral therapy in certain cases, and a new trial that could give hope to people with deadly liver cancer is one very promising example of this approach. Scientists are getting ready to test a revolutionary treatment that will entail injecting... (Source: NaturalNews.com)
Source: NaturalNews.com - July 25, 2017 Category: Consumer Health News Source Type: news

Preventing cancer with HPV vaccine
A vaccine exists that can actually prevent cancer, yet millions of people are not taking it. Dr. Tara Narula reports on how immunization against the human papillomavirus (or HPV) can prevent many cancers, but only two-thirds of girls and one-half of boys have received the vaccine. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - July 23, 2017 Category: Consumer Health News Source Type: news

HPV vaccine: Why aren't children getting it?
The most underutilized immunization for children can also prevent many forms of cancer - but one-third of girls and one-half of boys aren't being vaccinated (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - July 23, 2017 Category: Consumer Health News Source Type: news

Nutrition science isn ’ t broken, it ’ s just wicked hard
My dad is an old-school rancher who uses a flip-phone, refuses to wear a seat belt and swears by the Atkins diet. Like many Americans on both sides of the political aisle, he’s skeptical of science. But not because he thinks Al Gore invented climate change, vaccines cause autism or GMOs are an elaborate corporate […]Related:Coffee with Viagra-like ingredient recalled after FDA discoveryMost female homicide victims are killed by husbands or other intimate partners, new report shows5 questions about the brain cancer diagnosed in Sen. John McCain (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - July 21, 2017 Category: Consumer Health News Source Type: news

HPV vaccination in boys deemed not cost effective
JCVI concludes high uptake levels in girls in the UK means that vaccinating boys is not cost-effective Related items fromOnMedica Vaccinating girls against HPV benefits men HPV vaccine to be piloted in gay men Two-dose HPV vaccine schedule as good as three-dose Persistent HPV raises risk of anal and genital cancers (Source: OnMedica Latest News)
Source: OnMedica Latest News - July 20, 2017 Category: UK Health Source Type: news

HPV vaccine: anger over decision not to extend NHS scheme to boys
Health bodies condemn panel ’s conclusion that more jabs against cancer-causing infection are unlikely to be cost-effectiveA decision not to vaccinate boys against a cancer-causing sexually transmitted infection has been condemned by health bodies and campaigners.The Joint Committee on Vaccination and Immunisation (JCVI), which has been reviewing the human papilloma virus (HPV) vaccination programme, concluded that it was “highly unlikely to be cost-effective” to extend the scheme to include adolescent boys as well as girls.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - July 19, 2017 Category: Science Authors: Nicola Slawson Tags: HPV vaccine Vaccines and immunisation Sexual health NHS Cancer Society Children UK news Medical research Source Type: news

Plan not to give HPV vaccine to boys causes concern
Decision not to vaccinate boys against a cancer-causing sexually transmitted infection attracts fierce criticism. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - July 19, 2017 Category: Consumer Health News Source Type: news

HPV jabs for boys 'highly unlikely to be cost-effective' say DH advisers
DH advisers reviewing the HPV vaccination programme have concluded it is 'highly unlikely to be cost-effective' to extend the scheme to include adolescent boys as well as girls. (Source: GP Online News)
Source: GP Online News - July 19, 2017 Category: Primary Care Tags: Cancer Source Type: news

Papers of note in Nature 547 (7662)
This week’s articles describe mechanisms that control the proliferation of cardiac cells during injury repair, personalized vaccines for treating cancer, and a mechanism by which malaria parasites sense host nutrients. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - July 18, 2017 Category: Science Authors: VanHook, A. M. Tags: STKE Editors ' Choice Source Type: news

How Common Are STIs?
Discussion Of the 30 different microbes which can be transmitted by sexual contact, 8 have the greatest incidence of transmitting disease. Four are curable (Chlamydia, Gonorrhea, Syphilis and Trichomoniasis) and 4 are incurable at present (Hepatitis B, Herpes simplex virus (HSV), Human immunodeficiency virus (HIV) and Human papillomavirus (HPV)). Sexually transmitted infections (STIs) are important as they can cause: Increased rates of acquisition of other STIs (ie HSV and syphilis increase the rate of HIV infection acquisition) Pelvic inflammatory disease and infertility Stillbirth and neonatal death Neonatal morbidity i...
Source: PediatricEducation.org - July 17, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

HPV Infection Rates Plummet With Vaccination
Vaccination against HPV is preventing infections and will cause a drop in cervical cancer rates. The only reason more people aren't getting vaccinated is the superstitions of the antivaccination movement. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 12, 2017 Category: Pharmaceuticals Authors: Peter Lipson, Contributor Tags: NYSE:MRCK Source Type: news

Hepatitis B jab to be added to immunisations of babies born in UK
Babies born from the 1 August will be offered new “hexavalent” jab in effort to clamp down on infections that cause cirrhosis and liver cancerAll babies born in the UK will receive the hepatitis B jab as part of their routine immunisations from the autumn in an effort to drive down viral infections that cause cirrhosis and liver cancer.The hepatitis B vaccine is to be added to the 5-in-1 jab that is already given to babies across the UK to protect them from diphtheria, tetanus, whooping cough, polio and bacterial infections known as Hib, or haemophilus influenzae type b, health officials said.Continue reading.....
Source: Guardian Unlimited Science - July 9, 2017 Category: Science Authors: Ian Sample Science editor Tags: Hepatitis B Science Society Children UK news Source Type: news

This Bucks biotech exec got terminal cancer. It shattered his preconceived ideas on care
'There are vaccines available now that weren ’t when I was a teenager.' (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - July 7, 2017 Category: Health Management Authors: John George Source Type: news

Personalized Vaccines Hold Cancer at Bay in Two Early Trials Personalized Vaccines Hold Cancer at Bay in Two Early Trials
A novel class of personalized cancer vaccines, tailored to the tumors of individual patients, kept disease in check in two early-stage clinical trials, pointing to a new way to help the immune system fight back.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - July 6, 2017 Category: Allergy & Immunology Tags: Hematology-Oncology News Source Type: news

Personalized vaccines hold cancer at bay in two early trials
A novel class of personalized cancer vaccines, tailored to the tumors of individual patients, kept disease in check in two early-stage clinical trials, pointing to a new way to help the immune system fight back. (Source: Reuters: Health)
Source: Reuters: Health - July 5, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Personalized cancer vaccines could clear the disease
Researchers from the Dana-Farber Cancer Institute in Boston found that four out of six patients have been clear of their melanoma for nearly three years after been given one of the two vaccinations. (Source: the Mail online | Health)
Source: the Mail online | Health - July 5, 2017 Category: Consumer Health News Source Type: news

Personal neoantigen vaccine prompts strong anti-tumor response in patients, study shows
(Dana-Farber Cancer Institute) A personal cancer treatment vaccine that targets distinctive 'neoantigens' on tumor cells has been shown to stimulate a potent, safe, and highly specific immune anti-tumor response in melanoma patients, report scientists from Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 5, 2017 Category: Cancer & Oncology Source Type: news

Future of health care: Could PathoVax cure cancer?
43North winner tackles HPV vaccine in Buffalo. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 2, 2017 Category: Biotechnology Authors: Dan Miner Source Type: news

Future of health care: Could PathoVax cure cancer?
43North winner tackles HPV vaccine in Buffalo. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - July 2, 2017 Category: Health Management Authors: Dan Miner Source Type: news

Some women in the UK still unaware of cervical screening
Conclusion This study presents interesting findings on the proportion of women who don't go for cervical screening tests, and the possible reasons for their non-attendance. Researchers found most non-participants were either unaware of screening or intended to go to screening but still failed to go. This was most common in single women aged 25-34. One point to note is that the data was collected through self-reported questionnaires, which carry the risk of inaccurate reporting because of the perceived social stigma around screening and the desire to give the "right" response. In the case of cervical cancer scre...
Source: NHS News Feed - June 30, 2017 Category: Consumer Health News Tags: Cancer Source Type: news